← FDA DRUG APPROVALS

FDA ANDA · ANDA089127

MEPRO-ASPIRIN

Sponsor: SANDOZ

APPLICATION
ANDA089127
TYPE
ANDA
ORIGINAL APPROVAL
1994-09-16
LATEST ACTION
1994-09-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEPRO-ASPIRINDiscontinued
ASPIRIN 325MG, MEPROBAMATE 200MG · TABLET · ORAL

Approval history

1994-09-16OriginalAP
1988-11-18Labeling · Supplement 2AP
1988-05-26Labeling · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →